Exploring the impact of MDMA and oxytocin ligands on anxiety and social responses: A comprehensive behavioural and molecular study in the zebrafish model.
Journal of Psychopharmacology April 1, 2025 Monika Maciag, Olga Doszyn, Artur Wnorowski et al. 4 citations
Mental disorders, including anxiety and depression, impact nearly 1 billion people worldwide. Recent research has highlighted the potential of certain amphetamine compounds in the therapy of psychiatric disorders, with 3,4-methylenedioxymethamphetamine (MDMA) emerging as a promising candidate. This study investigates the effects of MDMA on anxiety and social behaviours using 3-week-old...
DOI: 10.1177/02698811251324596 (opens in new tab)
Full text (opens in new tab)
Molly
MDMA Ecstasy
Neurotransmitters
Oxytocin system
+7